IP-10 detection in urine is associated with lung diseases View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-11-22

AUTHORS

Angela Cannas, Ludovica Calvo, Teresa Chiacchio, Gilda Cuzzi, Valentina Vanini, Francesco N Lauria, Luigia Pucci, Enrico Girardi, Delia Goletti

ABSTRACT

BACKGROUND: Blood cytokines and chemokines have been proposed as biomarkers for tuberculosis (TB). Recently, some immune mediators found in the urine of patients with renal dysfunctions have also been suggested as potential biomarkers. Finding biomarkers for TB in urine would present several advantages over blood in terms of collection and safety. The objective of this study was to investigate the presence of cytokines and chemokines in the urine of patients with pulmonary TB at the time of diagnosis. In a subgroup, the evaluation was also performed during TB treatment and at therapy completion. Patients with lung diseases other than TB, and healthy subjects were also enrolled. METHODS: Urine samples from 138 individuals, after exclusion of renal dysfunctions, were collected during an 18 month-period. Among them, 58 received a diagnosis of pulmonary TB, 28 resulted having lung diseases other than TB, and 34 were healthy subjects. Moreover, 18 TB patients, 9 of whom were tested 2 months after AFB smear sputum reversion and 9 of whom were cured of TB were also included. Cytokines and chemokines in urine were evaluated using a Cytometric-Bead-Array-Flex-Set. IP-10 detection in 49 subjects was also carried out in parallel by using an Enzyme Linked ImmunoSorbent Assay (ELISA). RESULTS: IFN-γ, TNF-α, IL-2, IL-8, MIP-1α, MIP-1β and RANTES were poorly detected in all urine samples. Conversely, IP-10 was consistently detected in urine and its level was significantly increased in patients with lung disease compared to healthy subjects (p < 0.001). Increased IP-10 levels were found in both pulmonary TB and lung diseases other than TB. Moreover lower IP-10 levels were found in cured-TB patients compared to the levels at the time of diagnosis, and this difference was close to significance (p = 0.06). Interestingly, we demonstrated a significant correlation between the data obtained by flow cytometry and ELISA (r² 0.82, p < 0.0001). CONCLUSIONS: IP-10, in contrast to IFN-γ, TNF-α, IL-2, IL-8, MIP-1α, MIP-1β and RANTES, is detectable in the urine of patients with pulmonary diseases in the absence of renal dysfunctions. Moreover, the IP-10 level in cured-TB patients is comparable to that found in healthy subjects. More studies are needed to further investigate the clinical utility of these findings. More... »

PAGES

333-333

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2334-10-333

DOI

http://dx.doi.org/10.1186/1471-2334-10-333

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1052844800

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21092156


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemokine CXCL10", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemokines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytokines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme-Linked Immunosorbent Assay", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Flow Cytometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tuberculosis, Pulmonary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cannas", 
        "givenName": "Angela", 
        "id": "sg:person.0622436115.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622436115.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Calvo", 
        "givenName": "Ludovica", 
        "id": "sg:person.0737103324.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737103324.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chiacchio", 
        "givenName": "Teresa", 
        "id": "sg:person.01250107466.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250107466.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cuzzi", 
        "givenName": "Gilda", 
        "id": "sg:person.0604346205.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604346205.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vanini", 
        "givenName": "Valentina", 
        "id": "sg:person.0650313551.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650313551.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pneumology Unit, Health Department, INMI, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Pneumology Unit, Health Department, INMI, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lauria", 
        "givenName": "Francesco N", 
        "id": "sg:person.01050065003.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050065003.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Clinical Biochemistry and Pharmacology Laboratory, INMI, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Clinical Biochemistry and Pharmacology Laboratory, INMI, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pucci", 
        "givenName": "Luigia", 
        "id": "sg:person.0766710005.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766710005.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Girardi", 
        "givenName": "Enrico", 
        "id": "sg:person.01222655205.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222655205.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goletti", 
        "givenName": "Delia", 
        "id": "sg:person.01200446072.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200446072.99"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/pl00007615", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001543359", 
          "https://doi.org/10.1007/pl00007615"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/315672a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006952253", 
          "https://doi.org/10.1038/315672a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02715666", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022119750", 
          "https://doi.org/10.1007/bf02715666"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar1029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019499476", 
          "https://doi.org/10.1186/ar1029"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1020554817047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012368601", 
          "https://doi.org/10.1023/a:1020554817047"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12016-010-8197-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050483079", 
          "https://doi.org/10.1007/s12016-010-8197-z"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-11-22", 
    "datePublishedReg": "2010-11-22", 
    "description": "BACKGROUND: Blood cytokines and chemokines have been proposed as biomarkers for tuberculosis (TB). Recently, some immune mediators found in the urine of patients with renal dysfunctions have also been suggested as potential biomarkers. Finding biomarkers for TB in urine would present several advantages over blood in terms of collection and safety. The objective of this study was to investigate the presence of cytokines and chemokines in the urine of patients with pulmonary TB at the time of diagnosis. In a subgroup, the evaluation was also performed during TB treatment and at therapy completion. Patients with lung diseases other than TB, and healthy subjects were also enrolled.\nMETHODS: Urine samples from 138 individuals, after exclusion of renal dysfunctions, were collected during an 18 month-period. Among them, 58 received a diagnosis of pulmonary TB, 28 resulted having lung diseases other than TB, and 34 were healthy subjects. Moreover, 18 TB patients, 9 of whom were tested 2 months after AFB smear sputum reversion and 9 of whom were cured of TB were also included. Cytokines and chemokines in urine were evaluated using a Cytometric-Bead-Array-Flex-Set. IP-10 detection in 49 subjects was also carried out in parallel by using an Enzyme Linked ImmunoSorbent Assay (ELISA).\nRESULTS: IFN-\u03b3, TNF-\u03b1, IL-2, IL-8, MIP-1\u03b1, MIP-1\u03b2 and RANTES were poorly detected in all urine samples. Conversely, IP-10 was consistently detected in urine and its level was significantly increased in patients with lung disease compared to healthy subjects (p < 0.001). Increased IP-10 levels were found in both pulmonary TB and lung diseases other than TB. Moreover lower IP-10 levels were found in cured-TB patients compared to the levels at the time of diagnosis, and this difference was close to significance (p = 0.06). Interestingly, we demonstrated a significant correlation between the data obtained by flow cytometry and ELISA (r\u00b2 0.82, p < 0.0001).\nCONCLUSIONS: IP-10, in contrast to IFN-\u03b3, TNF-\u03b1, IL-2, IL-8, MIP-1\u03b1, MIP-1\u03b2 and RANTES, is detectable in the urine of patients with pulmonary diseases in the absence of renal dysfunctions. Moreover, the IP-10 level in cured-TB patients is comparable to that found in healthy subjects. More studies are needed to further investigate the clinical utility of these findings.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1471-2334-10-333", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024946", 
        "issn": [
          "1471-2334"
        ], 
        "name": "BMC Infectious Diseases", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "keywords": [
      "IP-10 levels", 
      "urine of patients", 
      "Enzyme Linked Immunosorbent Assay", 
      "IP-10 detection", 
      "time of diagnosis", 
      "lung disease", 
      "renal dysfunction", 
      "pulmonary tuberculosis", 
      "healthy subjects", 
      "MIP-1\u03b2", 
      "MIP-1\u03b1", 
      "IP-10", 
      "IL-8", 
      "IL-2", 
      "lower IP-10 levels", 
      "urine samples", 
      "presence of cytokines", 
      "Linked Immunosorbent Assay", 
      "TB patients", 
      "blood cytokines", 
      "TB treatment", 
      "therapy completion", 
      "immune mediators", 
      "pulmonary disease", 
      "clinical utility", 
      "patients", 
      "potential biomarkers", 
      "tuberculosis", 
      "flow cytometry", 
      "disease", 
      "cytometric beads", 
      "chemokines", 
      "dysfunction", 
      "immunosorbent assay", 
      "cytokines", 
      "urine", 
      "diagnosis", 
      "biomarkers", 
      "more studies", 
      "significant correlation", 
      "RANTES", 
      "IFN", 
      "TNF", 
      "subjects", 
      "levels", 
      "blood", 
      "months", 
      "cytometry", 
      "subgroups", 
      "treatment", 
      "mediators", 
      "study", 
      "safety", 
      "assays", 
      "findings", 
      "AFB", 
      "individuals", 
      "completion", 
      "samples", 
      "absence", 
      "differences", 
      "significance", 
      "evaluation", 
      "detection", 
      "time", 
      "contrast", 
      "correlation", 
      "exclusion", 
      "utility", 
      "presence", 
      "objective", 
      "reversion", 
      "data", 
      "collection", 
      "parallel", 
      "terms", 
      "advantages", 
      "terms of collection", 
      "set", 
      "sputum reversion", 
      "Array-Flex", 
      "cured-TB patients"
    ], 
    "name": "IP-10 detection in urine is associated with lung diseases", 
    "pagination": "333-333", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1052844800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2334-10-333"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21092156"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2334-10-333", 
      "https://app.dimensions.ai/details/publication/pub.1052844800"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:14", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_511.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1471-2334-10-333"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-333'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-333'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-333'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-333'


 

This table displays all metadata directly associated to this object as RDF triples.

285 TRIPLES      22 PREDICATES      128 URIs      114 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2334-10-333 schema:about N03cc182d8d5a421d98b6cb6a04449a16
2 N110604ee7d944ac78a4f21dcbdc79a8c
3 N13f1ec4a8c464a7d8ca2824bd99636ea
4 N18f8ba765f1748518c4a7cef9b5a91f1
5 N1e13738a2d5a4cf38d452f11d8c28bc3
6 N480b72af002d4068b7424f979ab300d4
7 N4b133cad21cd4cfe9c44c71ba2727273
8 N5b4a6ef2d0504a139de820f47c4c1aa5
9 N83596b9a3533494da805fea1a68f9f94
10 N8d13bd6bb8f5432f969a38bbda6eaae9
11 Ne141e6900dc1492095bc998a7061f408
12 Ne52689b579334924a5954afd00cfb158
13 Necc100d33d5c45baa3230e1a59f14b0f
14 Nfe905527f91d49119c8b3d542023a564
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author Na4b6a3cfcbec4f3fa6b67de6eaf02293
18 schema:citation sg:pub.10.1007/bf02715666
19 sg:pub.10.1007/pl00007615
20 sg:pub.10.1007/s12016-010-8197-z
21 sg:pub.10.1023/a:1020554817047
22 sg:pub.10.1038/315672a0
23 sg:pub.10.1186/ar1029
24 schema:datePublished 2010-11-22
25 schema:datePublishedReg 2010-11-22
26 schema:description BACKGROUND: Blood cytokines and chemokines have been proposed as biomarkers for tuberculosis (TB). Recently, some immune mediators found in the urine of patients with renal dysfunctions have also been suggested as potential biomarkers. Finding biomarkers for TB in urine would present several advantages over blood in terms of collection and safety. The objective of this study was to investigate the presence of cytokines and chemokines in the urine of patients with pulmonary TB at the time of diagnosis. In a subgroup, the evaluation was also performed during TB treatment and at therapy completion. Patients with lung diseases other than TB, and healthy subjects were also enrolled. METHODS: Urine samples from 138 individuals, after exclusion of renal dysfunctions, were collected during an 18 month-period. Among them, 58 received a diagnosis of pulmonary TB, 28 resulted having lung diseases other than TB, and 34 were healthy subjects. Moreover, 18 TB patients, 9 of whom were tested 2 months after AFB smear sputum reversion and 9 of whom were cured of TB were also included. Cytokines and chemokines in urine were evaluated using a Cytometric-Bead-Array-Flex-Set. IP-10 detection in 49 subjects was also carried out in parallel by using an Enzyme Linked ImmunoSorbent Assay (ELISA). RESULTS: IFN-γ, TNF-α, IL-2, IL-8, MIP-1α, MIP-1β and RANTES were poorly detected in all urine samples. Conversely, IP-10 was consistently detected in urine and its level was significantly increased in patients with lung disease compared to healthy subjects (p < 0.001). Increased IP-10 levels were found in both pulmonary TB and lung diseases other than TB. Moreover lower IP-10 levels were found in cured-TB patients compared to the levels at the time of diagnosis, and this difference was close to significance (p = 0.06). Interestingly, we demonstrated a significant correlation between the data obtained by flow cytometry and ELISA (r² 0.82, p < 0.0001). CONCLUSIONS: IP-10, in contrast to IFN-γ, TNF-α, IL-2, IL-8, MIP-1α, MIP-1β and RANTES, is detectable in the urine of patients with pulmonary diseases in the absence of renal dysfunctions. Moreover, the IP-10 level in cured-TB patients is comparable to that found in healthy subjects. More studies are needed to further investigate the clinical utility of these findings.
27 schema:genre article
28 schema:inLanguage en
29 schema:isAccessibleForFree true
30 schema:isPartOf N053f023ea797480cbd477c9b87b9c6f3
31 Nd5beb562fb034160a4391850e241bea4
32 sg:journal.1024946
33 schema:keywords AFB
34 Array-Flex
35 Enzyme Linked Immunosorbent Assay
36 IFN
37 IL-2
38 IL-8
39 IP-10
40 IP-10 detection
41 IP-10 levels
42 Linked Immunosorbent Assay
43 MIP-1α
44 MIP-1β
45 RANTES
46 TB patients
47 TB treatment
48 TNF
49 absence
50 advantages
51 assays
52 biomarkers
53 blood
54 blood cytokines
55 chemokines
56 clinical utility
57 collection
58 completion
59 contrast
60 correlation
61 cured-TB patients
62 cytokines
63 cytometric beads
64 cytometry
65 data
66 detection
67 diagnosis
68 differences
69 disease
70 dysfunction
71 evaluation
72 exclusion
73 findings
74 flow cytometry
75 healthy subjects
76 immune mediators
77 immunosorbent assay
78 individuals
79 levels
80 lower IP-10 levels
81 lung disease
82 mediators
83 months
84 more studies
85 objective
86 parallel
87 patients
88 potential biomarkers
89 presence
90 presence of cytokines
91 pulmonary disease
92 pulmonary tuberculosis
93 renal dysfunction
94 reversion
95 safety
96 samples
97 set
98 significance
99 significant correlation
100 sputum reversion
101 study
102 subgroups
103 subjects
104 terms
105 terms of collection
106 therapy completion
107 time
108 time of diagnosis
109 treatment
110 tuberculosis
111 urine
112 urine of patients
113 urine samples
114 utility
115 schema:name IP-10 detection in urine is associated with lung diseases
116 schema:pagination 333-333
117 schema:productId N156a438b27b2496eb36dd977982b4420
118 Nbbc99c8092f249e6abf81f77a864afba
119 Ne78ddba9c23245c8ae3a3cf3c1f6da47
120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052844800
121 https://doi.org/10.1186/1471-2334-10-333
122 schema:sdDatePublished 2021-11-01T18:14
123 schema:sdLicense https://scigraph.springernature.com/explorer/license/
124 schema:sdPublisher Nd9e9bec46a1745849c05764328c92eea
125 schema:url https://doi.org/10.1186/1471-2334-10-333
126 sgo:license sg:explorer/license/
127 sgo:sdDataset articles
128 rdf:type schema:ScholarlyArticle
129 N03cc182d8d5a421d98b6cb6a04449a16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Cytokines
131 rdf:type schema:DefinedTerm
132 N053f023ea797480cbd477c9b87b9c6f3 schema:volumeNumber 10
133 rdf:type schema:PublicationVolume
134 N0ddace03d9e04d8b8cfad0377ba5f7bd rdf:first sg:person.0604346205.97
135 rdf:rest Na75780015c064b94bb1ae954fc6d890e
136 N110604ee7d944ac78a4f21dcbdc79a8c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Biomarkers
138 rdf:type schema:DefinedTerm
139 N13f1ec4a8c464a7d8ca2824bd99636ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Female
141 rdf:type schema:DefinedTerm
142 N156a438b27b2496eb36dd977982b4420 schema:name dimensions_id
143 schema:value pub.1052844800
144 rdf:type schema:PropertyValue
145 N18f8ba765f1748518c4a7cef9b5a91f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Male
147 rdf:type schema:DefinedTerm
148 N1e13738a2d5a4cf38d452f11d8c28bc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Flow Cytometry
150 rdf:type schema:DefinedTerm
151 N417d5b5565284b0b9b984773e192e0f2 rdf:first sg:person.0766710005.24
152 rdf:rest N974315813c2245e6b383cd452750665f
153 N4247cccd3a7445a7a5c971dbf07a55d6 rdf:first sg:person.0737103324.09
154 rdf:rest N705c6e541622425189fdc85318473b63
155 N480b72af002d4068b7424f979ab300d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Young Adult
157 rdf:type schema:DefinedTerm
158 N4b133cad21cd4cfe9c44c71ba2727273 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Enzyme-Linked Immunosorbent Assay
160 rdf:type schema:DefinedTerm
161 N5b4a6ef2d0504a139de820f47c4c1aa5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Tuberculosis, Pulmonary
163 rdf:type schema:DefinedTerm
164 N705c6e541622425189fdc85318473b63 rdf:first sg:person.01250107466.00
165 rdf:rest N0ddace03d9e04d8b8cfad0377ba5f7bd
166 N83596b9a3533494da805fea1a68f9f94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Lung Diseases
168 rdf:type schema:DefinedTerm
169 N8d13bd6bb8f5432f969a38bbda6eaae9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Adult
171 rdf:type schema:DefinedTerm
172 N974315813c2245e6b383cd452750665f rdf:first sg:person.01222655205.82
173 rdf:rest Na127aa8b89c64a68ae5dbcde5a7bde51
174 Na127aa8b89c64a68ae5dbcde5a7bde51 rdf:first sg:person.01200446072.99
175 rdf:rest rdf:nil
176 Na1c16ae004194d7c91ab08d86dcd225f rdf:first sg:person.01050065003.28
177 rdf:rest N417d5b5565284b0b9b984773e192e0f2
178 Na4b6a3cfcbec4f3fa6b67de6eaf02293 rdf:first sg:person.0622436115.66
179 rdf:rest N4247cccd3a7445a7a5c971dbf07a55d6
180 Na75780015c064b94bb1ae954fc6d890e rdf:first sg:person.0650313551.19
181 rdf:rest Na1c16ae004194d7c91ab08d86dcd225f
182 Nbbc99c8092f249e6abf81f77a864afba schema:name doi
183 schema:value 10.1186/1471-2334-10-333
184 rdf:type schema:PropertyValue
185 Nd5beb562fb034160a4391850e241bea4 schema:issueNumber 1
186 rdf:type schema:PublicationIssue
187 Nd9e9bec46a1745849c05764328c92eea schema:name Springer Nature - SN SciGraph project
188 rdf:type schema:Organization
189 Ne141e6900dc1492095bc998a7061f408 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Chemokine CXCL10
191 rdf:type schema:DefinedTerm
192 Ne52689b579334924a5954afd00cfb158 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Humans
194 rdf:type schema:DefinedTerm
195 Ne78ddba9c23245c8ae3a3cf3c1f6da47 schema:name pubmed_id
196 schema:value 21092156
197 rdf:type schema:PropertyValue
198 Necc100d33d5c45baa3230e1a59f14b0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Adolescent
200 rdf:type schema:DefinedTerm
201 Nfe905527f91d49119c8b3d542023a564 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Chemokines
203 rdf:type schema:DefinedTerm
204 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
205 schema:name Medical and Health Sciences
206 rdf:type schema:DefinedTerm
207 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
208 schema:name Clinical Sciences
209 rdf:type schema:DefinedTerm
210 sg:journal.1024946 schema:issn 1471-2334
211 schema:name BMC Infectious Diseases
212 schema:publisher Springer Nature
213 rdf:type schema:Periodical
214 sg:person.01050065003.28 schema:affiliation grid-institutes:None
215 schema:familyName Lauria
216 schema:givenName Francesco N
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050065003.28
218 rdf:type schema:Person
219 sg:person.01200446072.99 schema:affiliation grid-institutes:None
220 schema:familyName Goletti
221 schema:givenName Delia
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200446072.99
223 rdf:type schema:Person
224 sg:person.01222655205.82 schema:affiliation grid-institutes:None
225 schema:familyName Girardi
226 schema:givenName Enrico
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222655205.82
228 rdf:type schema:Person
229 sg:person.01250107466.00 schema:affiliation grid-institutes:None
230 schema:familyName Chiacchio
231 schema:givenName Teresa
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250107466.00
233 rdf:type schema:Person
234 sg:person.0604346205.97 schema:affiliation grid-institutes:None
235 schema:familyName Cuzzi
236 schema:givenName Gilda
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604346205.97
238 rdf:type schema:Person
239 sg:person.0622436115.66 schema:affiliation grid-institutes:None
240 schema:familyName Cannas
241 schema:givenName Angela
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622436115.66
243 rdf:type schema:Person
244 sg:person.0650313551.19 schema:affiliation grid-institutes:None
245 schema:familyName Vanini
246 schema:givenName Valentina
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650313551.19
248 rdf:type schema:Person
249 sg:person.0737103324.09 schema:affiliation grid-institutes:None
250 schema:familyName Calvo
251 schema:givenName Ludovica
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737103324.09
253 rdf:type schema:Person
254 sg:person.0766710005.24 schema:affiliation grid-institutes:None
255 schema:familyName Pucci
256 schema:givenName Luigia
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766710005.24
258 rdf:type schema:Person
259 sg:pub.10.1007/bf02715666 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022119750
260 https://doi.org/10.1007/bf02715666
261 rdf:type schema:CreativeWork
262 sg:pub.10.1007/pl00007615 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001543359
263 https://doi.org/10.1007/pl00007615
264 rdf:type schema:CreativeWork
265 sg:pub.10.1007/s12016-010-8197-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1050483079
266 https://doi.org/10.1007/s12016-010-8197-z
267 rdf:type schema:CreativeWork
268 sg:pub.10.1023/a:1020554817047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012368601
269 https://doi.org/10.1023/a:1020554817047
270 rdf:type schema:CreativeWork
271 sg:pub.10.1038/315672a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006952253
272 https://doi.org/10.1038/315672a0
273 rdf:type schema:CreativeWork
274 sg:pub.10.1186/ar1029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019499476
275 https://doi.org/10.1186/ar1029
276 rdf:type schema:CreativeWork
277 grid-institutes:None schema:alternateName Clinical Biochemistry and Pharmacology Laboratory, INMI, Rome, Italy
278 Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy
279 Pneumology Unit, Health Department, INMI, Rome, Italy
280 Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy
281 schema:name Clinical Biochemistry and Pharmacology Laboratory, INMI, Rome, Italy
282 Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy
283 Pneumology Unit, Health Department, INMI, Rome, Italy
284 Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Rome, Italy
285 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...